Nextech Invest Ltd.
CIK 1595430
13F filing for Q2 2026・No. 1,580
- Holdings
- US$2.11B
- Quarter change
- +US$686.25M
- Entries
- 16
- Net bought (estimate)
- −US$30.01M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 2
- Sold out 4
- Cut 1
- Added 3
- Corporate actions 0
- Unchanged 9
Largest holdings
15 stocks worth US$2.11B, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| RVMDREVOLUTION MEDICINES INCCOM | Unchanged | 7,601,087 | US$1.42B | 67.55% |
| PARABILIS MEDICINES INCCOM | New | 4,663,176 | US$127.63M | 6.06% |
| RLAYRELAY THERAPEUTICS INCCOM | Added | 6,776,506 | US$126.79M | 6.02% |
| TYRA BIOSCIENCES INCCOM | Cut | 3,553,585 | US$113.5M | 5.39% |
| ALUMIS INCCOM | Unchanged | 3,540,998 | US$99.64M | 4.73% |
| ORIC PHARMACEUTICALS INCCOM | Unchanged | 7,162,637 | US$77.57M | 3.68% |
| KYMERA THERAPEUTICS INCCOM | Unchanged | 278,896 | US$31.98M | 1.52% |
| ZYMEWORKS INCCOM | Unchanged | 1,113,946 | US$29.12M | 1.38% |
| GLUEMONTE ROSA THERAPEUTICS INCCOM | Added | 761,153 | US$18.42M | 0.87% |
| ARVINAS INCCOM | Added | 1,122,713 | US$17.12M | 0.81% |
Sign in (free) to see its 15 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.